XTalks

MARCH 20, 2024

When it comes to leadership in clinical trials today, what qualities are necessary to navigate the evolving landscape of clinical research effectively? Xtalks recently had the opportunity to discuss Enciso’s journey in the clinical research industry and her decision to join Regeneron.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Clinical Research 52

XTalks

MARCH 25, 2021

Xtalks is proud to announce the launch of the Xtalks Life Science podcast. Subscribe to the Xtalks Life Science Podcast to never miss a new episode. Fresh Conversations About Life Science Topics. She focuses on news relating to the food industry and writes blogs on recruitment and HR in the life sciences.

Life Science 105

Life Science HR Clinical Trials Clinical Trials 105

pharmaphorum

JULY 7, 2022

Eradicating cancer is an ambitious goal for oncologists and life science companies around the world. But, with a growing number of cancer treatments entering the market each year and dedicated research efforts driving innovation in the sector, there are positive signs that the industry is on the right track.

Vaccination 52

Vaccination Vaccine Life Science Trials 52

XTalks

FEBRUARY 21, 2024

It is therefore important to work towards increasing Black participation in clinical trials, which begins with understanding the barriers to participation and taking steps to address them. Diversity in Clinical Trials Helps Advance Medicine Diverse participation in clinical trials is crucial for several reasons.

Clinical Trials 59

Clinical Trials Clinical Trials Trials Life Science 59

Drug Discovery World

OCTOBER 16, 2023

Scotland Saleko adds that Scotland, as a devolved nation, has an innovative NHS system that has propelled it to become a key site for translational medical research. From the Beatson Institute for Cancer Research in Glasgow, to Edinburgh Drug Discovery in the University of Edinburgh’s Institute for Genetics and Cancer (IGC).

Drugs 75

Drugs Life Science Gene Therapy Genome 75

XTalks

MAY 17, 2024

XTALKS CLINICAL EDGE: Issue 2 — Calliditas interview Xtalks Clinical Edge is a magazine for clinical research professionals and all who want to be informed about the latest trends and happenings in clinical trials. Therefore, it is not quite a rare disease there, says Dr. Phillipson.

Development 52

Development Drugs Clinical Trials Clinical Trials 52

XTalks

DECEMBER 28, 2023

Utilizing BillionToOne’s unique molecular counting technology, Quantitative Counting Templates (QCTs), the test employs next-generation sequencing (NGS) to detect genetic variants linked to the relevant fetal antigens. This test can be performed as early as the tenth week of pregnancy.

Trials 97

Trials Clinical Trials Clinical Trials Antibody 97

pharmaphorum

SEPTEMBER 28, 2022

The All of Us team is engaging these diverse communities to gather these datasets because it aims to use this information to impact clinical research. The datasets accelerate research primarily by acting as a resource to researchers, Mendoza says. Utilising the data. About the author.

Research 89

Research Medicine Clinical Trials Clinical Trials 89

XTalks

APRIL 13, 2022

About 80 percent of rare diseases have a genetic basis. Most rare diseases are chronic conditions, and many are clinically progressive and potentially fatal. Aspects of Pediatric Medical Research. Challenges in Pediatric Rare Disease Clinical Trials. Trial Considerations for Pediatric Rare Disease Clinical Research.

Clinical Trials 98

Clinical Trials Clinical Trials Clinical Research Trials 98

XTalks

APRIL 24, 2023

Approximately 72 percent of rare diseases are genetic, and around 70 percent of rare genetic diseases emerge in childhood. Watch the free, on-demand webinar and gain valuable insights from this team of clinical research experts. Rare diseases can often be progressive, chronic and fatal.

Gene Therapy 95

Gene Therapy Gene Trials Clinical Trials 95

pharmaphorum

MARCH 4, 2021

It might be tempting to think that because AI tools are machines, they are free from the subconscious biases and diversity issues that have long been problematic for clinical research. Abid leads the development of Cognitive Core, an AI platform created for the life sciences industry. About Intouch Group.

Life Science 86

Life Science Genetics Development Research 86

XTalks

JULY 25, 2022

Oncologists also test for breast cancer subtypes, which are based on genetic characteristics, to determine the most appropriate treatment. XTALKS WEBINAR: Discussing the Concerns within Clinical Research in Oncology and In-Home Healthcare. Live and On-Demand: Tuesday, August 30, 2022, at 11am EDT (4pm BST).

Antibody 59

Antibody Drugs Clinical Trials Clinical Trials 59

Cloudbyz

NOVEMBER 3, 2021

Biosamples and biomarkers are the core basis for much of the work done in the clinical research industry and proficient Human Biosample Management (HBSM) is necessary to procure reliable biosamples. Muscle tissues, nerve tissues, cell lines, blood cells, stem cells, and more. Sample Backup. Cost Recovery Fees for Biobanks.

Biobanking 52

Biobanking Clinical Research Contamination Research 52

XTalks

DECEMBER 14, 2023

Patient Services Case Managers ask questions about a pancreatic cancer patient’s diagnosis (type and stage of pancreatic cancer), their treatment history, results from biomarker testing and genetic testing for inherited mutations and geographic location to be able to search for a list of applicable clinical trials.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Doctors 52

Cloudbyz

MAY 19, 2021

Introduction Cell and gene therapy is an upcoming wave of therapeutic innovation in the healthcare and life sciences industry and is being pragmatically accepted worldwide. Moreover, 12% of industrial clinical pipeline products and at least 16% of preclinical pipeline products consist of CGT.

Gene Therapy 52

Gene Therapy Gene Manufacturing Production 52

pharmaphorum

JANUARY 27, 2023

She knows only too well how understanding the importance of patient centricity is crucial to the success of any modern life sciences company – but how has the landscape changed since 2019? “I It’s more the late-stage clinical trials that are not being commenced in the UK,” Dr Mullen elaborated. “So, We know that there are 3.5

Clinical Trials 103

Clinical Trials Clinical Trials Trials Development 103

The Pharma Data

DECEMBER 17, 2020

Most recently, Cadavid served as senior vice president and Head of Clinical Development at Fulcrum Therapeutics where he led the development of multiple small molecules for the treatment of genetically defined rare diseases. Recro – CDMO company Recro announced David Enloe as its new president and CEO.

Development 52

Development Gene Therapy Engineer Life Science 52

XTalks

FEBRUARY 24, 2023

When life sciences industry partners with patients and their advocacy communities, the patient voice becomes integrated into the drug development process. It’s an increasingly common and evolving practice that has brought about meaningful change in the clinical trial process.

Development 98

Development Clinical Trials Clinical Trials Gene Therapy 98

XTalks

SEPTEMBER 17, 2020

While clinical researchers occasionally need to identify and validate a new surrogate endpoint for a given trial, choosing endpoints that have been previously used as the basis of NDAs and BLAs can clear the path to eventual approval. Duchenne Muscular Dystrophy. Prevalence: 1 in 3,500. Lipodystrophy. Prevalence: 1 in 10 million.

Trials 98

Trials Gene Hormones Clinical Trials 98

XTalks

NOVEMBER 16, 2021

deVries co-founded Medidata in 1999 as a provider of technological software solutions to advance clinical research. Dassault Systèmes acquired the company in 2019 and de Vries was serving as the Life Sciences & Healthcare vice-chair for the new parent company.

Life Science 98

Life Science Clinical Research Pharma Companies Engineer 98

XTalks

JANUARY 15, 2024

The field of clinical research will witness significant advancements in 2024. Read on to learn about the top 10 clinical trial trends for 2024, and be sure to explore and join upcoming webinars about clinical trials at Xtalks. Blockchain can enhance data security and compliance by creating immutable data records.

Clinical Trials 105

Clinical Trials Clinical Trials Trials Clinical Research 105

Drug Discovery World

JANUARY 24, 2023

” 4,5,6 Asking the right questions Norstella is a newly formed company that aims to guide life sciences companies through drug development so patients can access therapies quicker. Quantifying the use of connected digital products in clinical research. Clinical Trial Tweaks Forced by Virus Should Stay, Hahn Says.

Clinical Trials 97

Clinical Trials Clinical Trials Drugs Trials 97

pharmaphorum

SEPTEMBER 12, 2022

Everyone’s genetic makeup differs, and each person’s cancer experience is unique to them – how cancer develops, how fast it spreads, which drugs it responds to, and more. Furthermore, each cancer has various gene changes – also referred to as the genetic makeup of cancer. Tailored oncology. About the author.

Genome 104

Genome Genomics Clinical Trials Clinical Trials 104

XTalks

DECEMBER 12, 2023

Moreover, combining biofluid analytes with molecular pathology (genetic biomarkers) allows for the classification and differentiation of neurodegenerative diseases. This shift not only enhances the precision of clinical trials but also opens up new avenues for patient-centric treatment approaches.

Trials 111

Trials Clinical Trials Clinical Trials Genetics 111

Drug Discovery World

AUGUST 3, 2023

Dr Sodergren told DDW in an exclusive comment: “I am hopeful that over the next few years we will see further investments by governments and funding bodies to accelerate pre-clinical and clinical research programmes. This was the largest ever independent study into cannabis use 10.

Medicine 52

Medicine Scientist Production Regulation 52

XTalks

FEBRUARY 4, 2021

Bernard, executive vice president for research and chief research officer at Vanderbilt University Medical Center, shared his experience in helping set up a DNA and clinical data resource called BioVU. Dr. Bernard’s clinical research interests are in the areas of sepsis and acute respiratory distress syndrome (ARDS).

Research 98

Research Biobanking Drugs Genome 98

XTalks

NOVEMBER 7, 2022

“Liquid biopsies have demonstrated promising activity in multiple clinical settings, but the great enthusiasm and expectations around them can be harmful if not adequately managed,” said Dr. El Mustapha Bahassi, PhD, Director, Clinical Laboratory Sciences, at the global clinical research organization (CRO) Medpace.

Clinical Trials 98

Clinical Trials Clinical Trials Trials FDA Approval 98

pharmaphorum

OCTOBER 7, 2021

Prior to that he was a pharmacist at the Pharmaceutical Establishment division of the Paris hospitals group AP-HP, where he was a project manager for the development of an orphan drug and a pharmaceutical contact for publicly-funded clinical studies. About IQVIA.

Genome 98

Genome Genomics Medicine Life Science 98

XTalks

MARCH 13, 2023

Over 70 percent of rare diseases are genetic, and of those, 70 percent begin in childhood. Since most rare diseases are genetically driven, gene therapies strive to fix the root cause of a disease instead of just treating a patient’s symptoms. There are around 300 million people worldwide living with a rare disease.

Gene Therapy 52

Gene Therapy Clinical Trials Clinical Trials Gene 52

XTalks

FEBRUARY 27, 2024

Rare Disease Day 2024, which falls on February 29 this year, is an opportunity to unite under a common cause: to bring attention to the challenges faced by those living with rare diseases and to push for advancements in research, treatment and policy.

Research 59

Research Drugs Gene Therapy Clinical Trials 59

XTalks

AUGUST 30, 2022

Clinical research experts from the CRO Medpace shared insights about the operational and regulatory considerations for neuroscience trials with direct CNS administration. The return of cell therapy-iPSCs (induced pluripotent stem cells) and genetically altered delivery cells. Reporter genes to understand dose and distribution.

Trials 83

Trials Drug Delivery Drugs Gene 83

XTalks

DECEMBER 1, 2020

As the research and medical community learns more about population variances in disease outcomes, whether as a result of regional genetic profiles, socioeconomic factors, or environmental inputs, it’s become necessary to ensure that clinical research trials include broad swaths of global participants.

Clinical Trials 96

Clinical Trials Clinical Trials Trials Clinical Research 96

XTalks

APRIL 1, 2022

Black, Hispanic and Native American/Indigenous populations remain grossly underrepresented in clinical trials. This is a problem as responses to treatments can vary between different racial groups owing to differences in genetics, physiology and lifestyle factors.

Clinical Trials 126

Clinical Trials Clinical Trials Trials Vaccination 126

XTalks

AUGUST 11, 2021

. “The most fundamental aspect of research is that we want to know which genes and pathways are the most relevant,” Elkon says. He describes how geneticists have identified at least 100 genetic variants that are enriched in lupus patients.

Development 105

Development Drugs Clinical Trials Clinical Trials 105

Drug Discovery World

FEBRUARY 6, 2023

Johannes Goll, Global Head of Emmes’ Biomedical Data Science and Bioinformatics department, explains how big data analytics can deliver improved therapies and bring clinical research one step close to realising the potential of personalised care.

Big Data 52

Big Data RNA Bioinformatics Vaccination 52

Drug Discovery World

AUGUST 10, 2022

For example, CD19 offers a sensitive and specific target for B cell lymphomas, but it does not appear on all tumour cells; therefore, researchers need to identify other targets to address other cancers. NK cells naturally attack tumour cells and do not need to be genetically modified to target a specific antigen.

Manufacturing 98

Manufacturing Gene Genome Genomics 98

XTalks

OCTOBER 1, 2020

Lin has made several transitions throughout her career, from being a clinician at an academic center, to academic research, to heading business development in industry. Working on finding therapies for genetic diseases at NeuBase, Dr. Sooter says, “Everyday, we get up and that’s our goal and it really drives everyone.

Scientist 52

Scientist In-Vitro Research Life Science 52